Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.3 now appears on the page, replacing Revision: v3.6.2. This indicates a minor backend update to the page template or content management system.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2, indicating a metadata version change rather than a change to the study details.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment status now indicates no participants are being sought, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) are added. The Intervention/Treatment heading formatting is standardized and the site revision updated to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedThe revision label on the page changed from v3.5.4 to v3.5.5, representing a small update in the page's revision history.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page release. No study data or user-facing content appears to be changed.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s displayed software/version revision was updated from **v3.5.2** to **v3.5.3**, without changing the underlying study information presented on the record.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.